Nutraceuticals in Acute and Prophylactic Treatment of Migraine

Opinion statement People who suffer from headaches often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible side effects, drug dependence, or addiction. Since treatment with nutraceuticals does not require a doctor’s prescription, many patients rely o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Current treatment options in neurology Ročník 18; číslo 4; s. 14
Hlavní autoři: Daniel, Oved, Mauskop, Alexander
Médium: Journal Article
Jazyk:angličtina
Vydáno: New York Springer US 01.04.2016
Témata:
Critical Care Medicine
Diabetes
Family Medicine
General Practice
Headache (JR Couch
Intensive
Internal Medicine
Medicine
Medicine & Public Health
Neurology
Ophthalmology
Section Editor
Topical Collection on Headache
Headache
Herbal preparation
Minerals
Migraine
Vitamins
Nutraceuticals
ISSN:1092-8480, 1534-3138
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Opinion statement People who suffer from headaches often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible side effects, drug dependence, or addiction. Since treatment with nutraceuticals does not require a doctor’s prescription, many patients rely on their own judgment as to when and which one to take, often without consultation or guidance from their physician. Some physicians could provide information about potential efficacy and side effects of various products, but many are not familiar with the nutraceuticals. Widespread skepticism persists among doctors about the effectiveness of these treatments. This is largely due to the lack of rigorous clinical studies. However, even when incontrovertible scientific evidence exists, many physicians remain distrustful of the evidence. The following review summarizes randomized controlled trials of some of the most commonly used non-pharmacological treatments, including magnesium, coenzyme Q 10 , riboflavin (vitamin B2), petasites, and feverfew (Table 1 ).
AbstractList People who suffer from headaches often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible side effects, drug dependence, or addiction. Since treatment with nutraceuticals does not require a doctor's prescription, many patients rely on their own judgment as to when and which one to take, often without consultation or guidance from their physician. Some physicians could provide information about potential efficacy and side effects of various products, but many are not familiar with the nutraceuticals. Widespread skepticism persists among doctors about the effectiveness of these treatments. This is largely due to the lack of rigorous clinical studies. However, even when incontrovertible scientific evidence exists, many physicians remain distrustful of the evidence. The following review summarizes randomized controlled trials of some of the most commonly used non-pharmacological treatments, including magnesium, coenzyme Q10, riboflavin (vitamin B2), petasites, and feverfew (Table 1).
Opinion statement People who suffer from headaches often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible side effects, drug dependence, or addiction. Since treatment with nutraceuticals does not require a doctor’s prescription, many patients rely on their own judgment as to when and which one to take, often without consultation or guidance from their physician. Some physicians could provide information about potential efficacy and side effects of various products, but many are not familiar with the nutraceuticals. Widespread skepticism persists among doctors about the effectiveness of these treatments. This is largely due to the lack of rigorous clinical studies. However, even when incontrovertible scientific evidence exists, many physicians remain distrustful of the evidence. The following review summarizes randomized controlled trials of some of the most commonly used non-pharmacological treatments, including magnesium, coenzyme Q 10 , riboflavin (vitamin B2), petasites, and feverfew (Table 1 ).
OPINION STATEMENTPeople who suffer from headaches often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible side effects, drug dependence, or addiction. Since treatment with nutraceuticals does not require a doctor's prescription, many patients rely on their own judgment as to when and which one to take, often without consultation or guidance from their physician. Some physicians could provide information about potential efficacy and side effects of various products, but many are not familiar with the nutraceuticals. Widespread skepticism persists among doctors about the effectiveness of these treatments. This is largely due to the lack of rigorous clinical studies. However, even when incontrovertible scientific evidence exists, many physicians remain distrustful of the evidence. The following review summarizes randomized controlled trials of some of the most commonly used non-pharmacological treatments, including magnesium, coenzyme Q10, riboflavin (vitamin B2), petasites, and feverfew (Table 1).
ArticleNumber 14
Author Daniel, Oved
Mauskop, Alexander
Author_xml – sequence: 1
  givenname: Oved
  surname: Daniel
  fullname: Daniel, Oved
  email: drmigrena@gmail.com
  organization: Headache & Facial Pain Clinic, Laniado Medical Center
– sequence: 2
  givenname: Alexander
  surname: Mauskop
  fullname: Mauskop, Alexander
  organization: Clinical Neurology, SUNY Downstate Medical Center, New York Headache Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26923604$$D View this record in MEDLINE/PubMed
BookMark eNp9kMtOxCAUQIkZo-PoB7gxXbqpQqEUNiZm4ivxtRjXhNKLYjp0BLrw78VUXbiYFSScc284B2jmBw8IHRN8RjBuziMhkuESE15iKkVJdtCc1JSVlFAxy3csq1IwgffRQYzvGFc1I2QP7VdcVpRjNkcXj2MK2sCYnNF9LJwvLs2YoNC-K57DsHn77LXJj8UqgE5r8KkYbPHgXoN2Hg7Rrs0aHP2cC_RyfbVa3pb3Tzd3y8v70lDGUsmssaTtOIi6MwSA2soazTvQTS2NrS2ANG0lOl4breu2YbKpbCewFdJSKugCnU5zN2H4GCEmtXbRQN9rD8MYFWm45DkGpxk9-UHHdg2d2gS31uFT_f45A2QCTBhiDGD_EILVd1c1dVW5q_ruqkh2mn-OcUknN_hcz_VbzWoyY97iXyGo92EMPsfaIn0B9mWMZQ
CitedBy_id crossref_primary_10_1080_1028415X_2019_1627770
crossref_primary_10_1186_s12906_017_1933_7
crossref_primary_10_1016_j_biopha_2018_03_059
crossref_primary_10_1080_1028415X_2017_1421039
crossref_primary_10_3389_fneur_2022_864689
crossref_primary_10_3897_pharmacia_71_e112909
crossref_primary_10_1186_s13052_019_0624_z
crossref_primary_10_3390_antiox9020116
crossref_primary_10_1111_ejn_15676
crossref_primary_10_3390_ijerph18041503
crossref_primary_10_1007_s10072_017_2901_1
crossref_primary_10_1136_bmjopen_2020_039358
crossref_primary_10_1007_s12011_019_01931_z
crossref_primary_10_1080_24725579_2017_1403520
crossref_primary_10_3390_nu16142222
crossref_primary_10_7759_cureus_14868
crossref_primary_10_1080_14656566_2022_2102420
crossref_primary_10_3390_jcm10010067
crossref_primary_10_1007_s10072_017_2896_7
crossref_primary_10_3390_neurolint15030073
crossref_primary_10_3390_nu14051089
crossref_primary_10_1136_practneurol_2019_002199
crossref_primary_10_3390_pharmaceutics13020251
crossref_primary_10_3389_fnut_2025_1497207
crossref_primary_10_1186_s10194_021_01234_6
crossref_primary_10_1186_s13052_020_00853_0
crossref_primary_10_1080_1028415X_2021_1904542
crossref_primary_10_3390_nu13072307
crossref_primary_10_1055_a_2508_4009
crossref_primary_10_3389_fnut_2021_653765
crossref_primary_10_1097_WCO_0000000000001204
Cites_doi 10.1046/j.1468-2982.2002.00335.x
10.1046/j.1468-2982.1996.1604257.x
10.1097/FPC.0b013e32832af5a3
10.1016/S0140-6736(88)92289-1
10.1177/0333102412451357
10.1111/j.1526-4610.2007.00652.x
10.1042/cs0890633
10.1136/bmj.291.6495.569
10.1186/s10194-015-0544-2
10.1212/WNL.50.2.466
10.5414/CPP38430
10.1002/(SICI)1099-1573(199711)11:7<508::AID-PTR153>3.0.CO;2-H
10.1212/01.WNL.0000147290.68260.11
10.1016/S0944-7113(96)80057-2
10.1111/j.2042-7158.1988.tb07010.x
10.2165/11586800-000000000-00000
10.1212/01.WNL.0000151975.03598.ED
10.1111/j.2042-7158.1987.tb03420.x
10.1177/0333102409355601
10.1046/j.1468-2982.2002.00364.x
10.1111/j.1526-4610.2011.01846.x
10.1111/j.1468-2982.2005.00950.x
10.1016/S0140-6736(85)92371-2
10.1046/j.1468-2982.1998.1810704.x
10.1046/j.1468-2982.1993.1302094.x
10.1111/j.1526-4610.2005.05044.x
10.1517/13543784.2011.601741
10.1111/j.1526-4610.1994.hed3403160.x
10.1212/01.wnl.0000323925.29520.e7
10.1046/j.1468-2982.1996.1606436.x
10.1111/j.1468-2982.2009.01849.x
10.1212/WNL.0b013e3181a41269
10.1046/j.1526-4610.2002.02026.x
10.1111/j.1526-4610.1989.hed2909590.x
10.1046/j.1468-2982.2002.00396.x
10.1212/WNL.0b013e3182535d0c
10.4274/npa.y6809
10.7861/clinmedicine.15-4-344
ContentType Journal Article
Copyright Springer Science+Business Media New York 2016
Copyright_xml – notice: Springer Science+Business Media New York 2016
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1007/s11940-016-0398-1
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1534-3138
EndPage 14
ExternalDocumentID 26923604
10_1007_s11940_016_0398_1
Genre Journal Article
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29F
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
5GY
5VS
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAQQT
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACSNA
ACZOJ
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
AXYYD
B-.
BA0
BDATZ
BGNMA
C1A
CAG
COF
CS3
CSCUP
CUV
DDRTE
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EJD
ESBYG
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
H13
HF~
HG6
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
I~Z
J-C
JBSCW
JZLTJ
KOV
LLZTM
M4Y
MA-
NPVJJ
NQJWS
NU0
O9-
O9J
OVD
P9S
PF0
PT4
PT5
QOR
QOS
R89
R9I
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
YLTOR
Z7U
Z81
Z82
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFFHD
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PSYQQ
NPM
7X8
ID FETCH-LOGICAL-c344t-4fcf1bd6e85dc1ee3f2fca6dea759cf5fee9cb28d65caa5b74972fd80f89f3383
IEDL.DBID RSV
ISICitedReferencesCount 36
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000372252900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1092-8480
IngestDate Fri Jul 11 16:34:55 EDT 2025
Thu Apr 03 06:57:39 EDT 2025
Sat Nov 29 02:36:08 EST 2025
Tue Nov 18 22:37:05 EST 2025
Fri Feb 21 02:35:56 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Headache
Herbal preparation
Minerals
Migraine
Vitamins
Nutraceuticals
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c344t-4fcf1bd6e85dc1ee3f2fca6dea759cf5fee9cb28d65caa5b74972fd80f89f3383
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 26923604
PQID 1769619463
PQPubID 23479
PageCount 1
ParticipantIDs proquest_miscellaneous_1769619463
pubmed_primary_26923604
crossref_primary_10_1007_s11940_016_0398_1
crossref_citationtrail_10_1007_s11940_016_0398_1
springer_journals_10_1007_s11940_016_0398_1
PublicationCentury 2000
PublicationDate 20160400
2016-4-00
2016-Apr
20160401
PublicationDateYYYYMMDD 2016-04-01
PublicationDate_xml – month: 4
  year: 2016
  text: 20160400
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Current treatment options in neurology
PublicationTitleAbbrev Curr Treat Options Neurol
PublicationTitleAlternate Curr Treat Options Neurol
PublicationYear 2016
Publisher Springer US
Publisher_xml – name: Springer US
References Makheja, Bailey (CR36) 1982; 8
Diener, Solbach, Holle, Gaul (CR3) 2015; 15
Gallai, Sarchielli, Morucci, Abbritti (CR24) 1994; 34
Bekkelund, Alstadhaug (CR47) 2011; 20
Kuritzky, Elhacham, Yerushalmi, Hering (CR39) 1994; 44
Vogler, Pittler, Ernst (CR42) 1998; 18
Sandor, Di Clemente, Coppola, Saenger, Fumal, Magis (CR30) 2005; 64
Trauninger, Pfund, Koszegi, Czopf (CR25) 2002; 42
GöKSEL (CR5) 2013; 50
Heptinstall, Goenewegen, Spangenberg, Loesche (CR34) 1987; 39
Lampl, Haider, Schweiger (CR45) 2012; 32
Sun‐Edelstein, Mauskop (CR7) 2011; 51
Di Lorenzo, Pierelli, Coppola, Grieco, Rengo, Ciccolella (CR31) 2009; 72
Palevitch, Earon, Carasso (CR41) 1997; 11
Steiner, Birbeck, Jensen, Katsarava, Stovner, Martelletti (CR2) 2015; 16
Mauskop (CR8) 2012; 18
Johnson, Kadam, Hylands, Hylands (CR37) 1985; 291
Schimatschek, Rempis (CR20) 2001; 14
Pfaffenrath, Wessely, Meyer, Isler, Evers, Grotemeyer (CR9) 1996; 16
Rozen, Oshinsky, Gebeline, Bradley, Young, Schechter (CR29) 2002; 22
Grossmann, Schmidramsl (CR15) 2000; 38
Draves, Walker (CR43) 2003; 136
Murphy, Heptinstall, Mitchell (CR38) 1988; 2
Pringsheim, Davenport, Mackie, Worthington, Aubé, Christie (CR32) 2012; 39
Peres, Goncalves (CR48) 2013; 80
Victor, Hu, Campbell, Buse, Lipton (CR1) 2010; 30
Bigal, Serrano, Reed, Lipton (CR4) 2008; 71
Tepper (CR6) 2015; 21
Storer, Goadsby (CR26) 2009; 29
Peikert, Wilimzig, Köhne-Volland (CR10) 1996; 16
Abdel-Tawab, Werz, Schubert-Zsilavecz (CR44) 2011; 50
Schoenen, Jacquy, Lanaerts (CR13) 1998; 50
Diener, Pfaffenrath, Schnitker, Friede, Henneicke‐von Zepelin (CR17) 2005; 25
Pothmann, Danesch (CR14) 2005; 45
Lipton, Gobel, Einhaupl, Wilks, Mauskop (CR16) 2004; 63
Lea, Colson, Quinlan, Macmillan, Griffiths (CR19) 2009; 19
Holland, Silberstein, Freitag, Dodick, Argoff, Ashman (CR27) 2012; 78
CR46
Ramadan, Halvorson, Vande-Linde (CR21) 1989; 29
Mauskop, Altura, Cracco, Altura (CR22) 1995; 89
De Weerdt, Bootsma, Hendriks (CR40) 1996; 3
Bigal, Bordini, Tepper, Speciali (CR11) 2002; 22
Choi, Parmar (CR28) 2014; 21
Pugh, Sambo (CR35) 1988; 40
Gallai, Sarchielli, Morucci, Abbritti (CR23) 1993; 13
Pfaffenrath, Diener, Fisher, Friede, Henneicke-von Zepelin (CR18) 2002; 22
Hershey, Powers, Vockell (CR12) 2007; 47
Heptinstall, Williamson, White, Mitchell (CR33) 1985; 325
TJ Steiner (398_CR2) 2015; 16
A Peikert (398_CR10) 1996; 16
PS Sandor (398_CR30) 2005; 64
TW Victor (398_CR1) 2010; 30
BK GöKSEL (398_CR5) 2013; 50
HC Diener (398_CR17) 2005; 25
T Pringsheim (398_CR32) 2012; 39
S Heptinstall (398_CR34) 1987; 39
ES Johnson (398_CR37) 1985; 291
R Pothmann (398_CR14) 2005; 45
RB Lipton (398_CR16) 2004; 63
M Grossmann (398_CR15) 2000; 38
WH Pugh (398_CR35) 1988; 40
M Peres (398_CR48) 2013; 80
A Mauskop (398_CR8) 2012; 18
V Pfaffenrath (398_CR9) 1996; 16
S Holland (398_CR27) 2012; 78
SJ Tepper (398_CR6) 2015; 21
AM Makheja (398_CR36) 1982; 8
C Lampl (398_CR45) 2012; 32
SI Bekkelund (398_CR47) 2011; 20
TD Rozen (398_CR29) 2002; 22
AD Hershey (398_CR12) 2007; 47
V Pfaffenrath (398_CR18) 2002; 22
V Gallai (398_CR24) 1994; 34
M Abdel-Tawab (398_CR44) 2011; 50
D Palevitch (398_CR41) 1997; 11
R Lea (398_CR19) 2009; 19
JJ Murphy (398_CR38) 1988; 2
HF Schimatschek (398_CR20) 2001; 14
AH Draves (398_CR43) 2003; 136
C Lorenzo Di (398_CR31) 2009; 72
S Heptinstall (398_CR33) 1985; 325
V Gallai (398_CR23) 1993; 13
RJ Storer (398_CR26) 2009; 29
A Trauninger (398_CR25) 2002; 42
A Kuritzky (398_CR39) 1994; 44
J Schoenen (398_CR13) 1998; 50
C Sun‐Edelstein (398_CR7) 2011; 51
HC Diener (398_CR3) 2015; 15
H Choi (398_CR28) 2014; 21
398_CR46
NM Ramadan (398_CR21) 1989; 29
A Mauskop (398_CR22) 1995; 89
ME Bigal (398_CR11) 2002; 22
ME Bigal (398_CR4) 2008; 71
CJ Weerdt De (398_CR40) 1996; 3
BK Vogler (398_CR42) 1998; 18
12110110 - Cephalalgia. 2002 Jun;22(5):345-53
23921817 - Eur J Emerg Med. 2014 Feb;21(1):2-9
21553931 - Clin Pharmacokinet. 2011 Jun;50(6):349-69
2886604 - J Pharm Pharmacol. 1987 Jun;39(6):459-65
3929876 - Br Med J (Clin Res Ed). 1985 Aug 31;291(6495):569-73
21352222 - Headache. 2011 Mar;51(3):469-483
15836592 - Headache. 2005 Mar;45(3):196-203
22868542 - Continuum (Minneap Minn). 2012 Aug;18(4):796-806
12230594 - Cephalalgia. 2002 Sep;22(7):523-32
11794636 - Magnes Res. 2001 Dec;14(4):283-90
17355497 - Headache. 2007 Jan;47(1):73-80
12005285 - Headache. 2002 Feb;42(2):114-9
19384265 - Pharmacogenet Genomics. 2009 Jun;19(6):422-8
9950629 - Cephalalgia. 1998 Dec;18(10):704-8
11972582 - Cephalalgia. 2002 Mar;22(2):137-41
9484373 - Neurology. 1998 Feb;50(2):466-70
8792038 - Cephalalgia. 1996 Jun;16(4):257-63
22767962 - Cephalalgia. 2012 Jul;32(9):719-22
16232154 - Cephalalgia. 2005 Nov;25(11):1031-41
6810384 - Prostaglandins Leukot Med. 1982 Jun;8(6):653-60
2584000 - Headache. 1989 Oct;29(9):590-3
22529203 - Neurology. 2012 Apr 24;78(17):1346-53
2899663 - Lancet. 1988 Jul 23;2(8604):189-92
8902254 - Cephalalgia. 1996 Oct;16(6):436-40
8549082 - Clin Sci (Lond). 1995 Dec;89(6):633-6
21819271 - Expert Opin Investig Drugs. 2011 Sep;20(9):1201-10
19414726 - Neurology. 2009 May 5;72(18):1588-94
11020030 - Int J Clin Pharmacol Ther. 2000 Sep;38(9):430-5
8200791 - Headache. 1994 Mar;34(3):160-5
28360583 - Noro Psikiyatr Ars. 2013 Aug;50(Suppl 1):S41-S46
26109437 - J Headache Pain. 2015;16:58
20713557 - Cephalalgia. 2010 Sep;30(9):1065-72
2860288 - Lancet. 1985 May 11;1(8437):1071-4
22683887 - Can J Neurol Sci. 2012 Mar;39(2 Suppl 2):S1-59
23195074 - Phytomedicine. 1996 Nov;3(3):225-30
15728298 - Neurology. 2005 Feb 22;64(4):713-5
18711108 - Neurology. 2008 Aug 19;71(8):559-66
2907548 - J Pharm Pharmacol. 1988 Oct;40(10 ):743-5
8495462 - Cephalalgia. 1993 Apr;13(2):94-81; discussion 73
26252588 - Continuum (Minneap Minn). 2015 Aug;21(4 Headache):1018-31
15623680 - Neurology. 2004 Dec 28;63(12):2240-4
26407383 - Clin Med (Lond). 2015 Aug;15(4):344-50
References_xml – volume: 22
  start-page: 137
  year: 2002
  end-page: 41
  ident: CR29
  article-title: Open label trial of Coenzyme Q10 as a migraine preventive
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2002.00335.x
– volume: 16
  start-page: 257
  issue: 4
  year: 1996
  end-page: 63
  ident: CR10
  article-title: Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1996.1604257.x
– volume: 21
  start-page: 2
  issue: 1
  year: 2014
  end-page: 9
  ident: CR28
  article-title: The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials
  publication-title: Eur J Emerg Med
– volume: 19
  start-page: 422
  issue: 6
  year: 2009
  end-page: 8
  ident: CR19
  article-title: The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability
  publication-title: Pharmacogenet Genomics
  doi: 10.1097/FPC.0b013e32832af5a3
– volume: 14
  start-page: 283
  issue: 4
  year: 2001
  end-page: 90
  ident: CR20
  article-title: Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals
  publication-title: Magnes Res: Off Organ Int Soc Dev Res Magnes
– volume: 2
  start-page: 189
  year: 1988
  end-page: 92
  ident: CR38
  article-title: Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
  publication-title: Lancet
  doi: 10.1016/S0140-6736(88)92289-1
– volume: 32
  start-page: 719
  issue: 9
  year: 2012
  end-page: 22
  ident: CR45
  article-title: Long-term efficacy of Boswellia serrata in four patients with chronic cluster headache
  publication-title: Cephalalgia
  doi: 10.1177/0333102412451357
– volume: 47
  start-page: 73
  year: 2007
  end-page: 80
  ident: CR12
  article-title: Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2007.00652.x
– volume: 89
  start-page: 633
  year: 1995
  end-page: 6
  ident: CR22
  article-title: Intravenous magnesium sulfate relieves acute migraine in patients with low serum ionized magnesium levels
  publication-title: Clin Sci
  doi: 10.1042/cs0890633
– volume: 291
  start-page: 569
  year: 1985
  end-page: 73
  ident: CR37
  article-title: Efficacy of feverfew as prophylactic treatment of migraine
  publication-title: Br Med J
  doi: 10.1136/bmj.291.6495.569
– volume: 8
  start-page: 653
  year: 1982
  end-page: 60
  ident: CR36
  article-title: A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium)
  publication-title: Prostaglandins Leukot Med
– volume: 16
  start-page: 1
  issue: 1
  year: 2015
  end-page: 3
  ident: CR2
  article-title: Headache disorders are third cause of disability worldwide
  publication-title: J Headache Pain
  doi: 10.1186/s10194-015-0544-2
– volume: 50
  start-page: 466
  year: 1998
  end-page: 70
  ident: CR13
  article-title: Effectiveness of high-dose riboflavin in migraine prophylaxis
  publication-title: Neurology
  doi: 10.1212/WNL.50.2.466
– volume: 136
  start-page: 23
  issue: 10
  year: 2003
  end-page: 30
  ident: CR43
  article-title: Parthenolide content of Canadian commercial feverfew preparations: label claims are misleading in most cases
  publication-title: CPJ, Can Pharm J
– volume: 38
  start-page: 430
  issue: 9
  year: 2000
  end-page: 5
  ident: CR15
  article-title: An extract of Petasites hybridus is effective in the prophylaxis of migraine
  publication-title: Int J Clin Pharmacol Ther
  doi: 10.5414/CPP38430
– volume: 15
  start-page: 344
  issue: 4
  year: 2015
  end-page: 50
  ident: CR3
  article-title: Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options
  publication-title: Clin Med
– volume: 18
  start-page: 796
  issue: 4, Headache
  year: 2012
  end-page: 806
  ident: CR8
  article-title: Nonmedication, alternative, and complementary treatments for migraine
  publication-title: CONTINUUM: Lifelong Learn Neurol
– volume: 11
  start-page: 508
  year: 1997
  end-page: 11
  ident: CR41
  article-title: Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a placebo-controlled doulbe-blind study
  publication-title: Phytother Res
  doi: 10.1002/(SICI)1099-1573(199711)11:7<508::AID-PTR153>3.0.CO;2-H
– volume: 80
  start-page: S40
  issue: Meeting Abstracts 1
  year: 2013
  end-page: 005
  ident: CR48
  article-title: Double-blind, placebo controlled, randomized clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention
  publication-title: Neurology
– volume: 63
  start-page: 2240
  year: 2004
  end-page: 4
  ident: CR16
  article-title: Petsites hybridus root (butterbur) is an effective preventive treatment for migraine
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000147290.68260.11
– volume: 3
  start-page: 225
  issue: 3
  year: 1996
  end-page: 30
  ident: CR40
  article-title: Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation
  publication-title: Phytomedicine
  doi: 10.1016/S0944-7113(96)80057-2
– volume: 40
  start-page: 743
  year: 1988
  end-page: 5
  ident: CR35
  article-title: Prostaglandin synthetase inhibitors in feverfew
  publication-title: J Pharm Pharmacol
  doi: 10.1111/j.2042-7158.1988.tb07010.x
– ident: CR46
– volume: 50
  start-page: 349
  issue: 6
  year: 2011
  end-page: 69
  ident: CR44
  article-title: Boswellia serrata
  publication-title: Clin Pharmacokinet
  doi: 10.2165/11586800-000000000-00000
– volume: 64
  start-page: 713
  issue: 4
  year: 2005
  end-page: 5
  ident: CR30
  article-title: Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000151975.03598.ED
– volume: 39
  start-page: 459
  year: 1987
  end-page: 65
  ident: CR34
  article-title: Extracts of feverfew may inhibit platelet behaviour via neutralisation of suphydryl groups
  publication-title: J Pharm Pharmacol
  doi: 10.1111/j.2042-7158.1987.tb03420.x
– volume: 30
  start-page: 065
  year: 2010
  end-page: 1072
  ident: CR1
  article-title: Migraine prevalence by age and sex in the United States: a life-span study
  publication-title: Cephalalgia
  doi: 10.1177/0333102409355601
– volume: 22
  start-page: 345
  issue: 5
  year: 2002
  end-page: 53
  ident: CR11
  article-title: Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2002.00364.x
– volume: 51
  start-page: 469
  issue: 3
  year: 2011
  end-page: 83
  ident: CR7
  article-title: Alternative headache treatments: nutraceuticals, behavioral and physical treatments
  publication-title: Headache: J Head Face Pain
  doi: 10.1111/j.1526-4610.2011.01846.x
– volume: 25
  start-page: 1031
  issue: 11
  year: 2005
  end-page: 41
  ident: CR17
  article-title: Efficacy and safety of 6.25 mg tid feverfew CO2‐extract (MIG‐99) in migraine prevention—a randomized, double‐blind, multicentre, Placebo‐controlled study
  publication-title: Cephalalgia
  doi: 10.1111/j.1468-2982.2005.00950.x
– volume: 325
  start-page: 1071
  issue: 8437
  year: 1985
  end-page: 4
  ident: CR33
  article-title: Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes
  publication-title: Lancet
  doi: 10.1016/S0140-6736(85)92371-2
– volume: 18
  start-page: 704
  year: 1998
  end-page: 8
  ident: CR42
  article-title: Feverfew as a preventive treatment for migraine: a systematic review
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1998.1810704.x
– volume: 13
  start-page: 94
  issue: 2
  year: 1993
  end-page: 8
  ident: CR23
  article-title: Red blood cell magnesium levels in migraine patients
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1993.1302094.x
– volume: 45
  start-page: 196
  year: 2005
  end-page: 203
  ident: CR14
  article-title: Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2005.05044.x
– volume: 44
  start-page: 293
  issue: Suppl 2
  year: 1994
  ident: CR39
  article-title: Feverfew in the treatment of migraine: its effect on serotonin uptake and platelet activity
  publication-title: Neurology
– volume: 20
  start-page: 1201
  issue: 9
  year: 2011
  end-page: 10
  ident: CR47
  article-title: Migraine prophylactic drugs-something new under the sun
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543784.2011.601741
– volume: 34
  start-page: 160
  issue: 3
  year: 1994
  end-page: 5
  ident: CR24
  article-title: Magnesium content of mononuclear blood cells in migraine patients
  publication-title: Headache: J Head Face Pain
  doi: 10.1111/j.1526-4610.1994.hed3403160.x
– volume: 71
  start-page: 559
  issue: 8
  year: 2008
  end-page: 66
  ident: CR4
  article-title: Chronic migraine in the population Burden, diagnosis, and satisfaction with treatment
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000323925.29520.e7
– volume: 16
  start-page: 436
  issue: 6
  year: 1996
  end-page: 40
  ident: CR9
  article-title: Magnesium in the prophylaxis of migraine—a double-blind, placebo-controlled study
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1996.1606436.x
– volume: 29
  start-page: 135
  year: 2009
  ident: CR26
  article-title: N-Methyl-D-Aspartate receptor channel complex blockers including memantine and magnesium inhibit nociceptive traffic in the trigeminocervical complex of the rat
  publication-title: Cephalalgia
  doi: 10.1111/j.1468-2982.2009.01849.x
– volume: 72
  start-page: 1588
  issue: 18
  year: 2009
  end-page: 94
  ident: CR31
  article-title: Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181a41269
– volume: 42
  start-page: 114
  year: 2002
  end-page: 9
  ident: CR25
  article-title: Oral magnesium load test in patients with migraine
  publication-title: Headache
  doi: 10.1046/j.1526-4610.2002.02026.x
– volume: 29
  start-page: 590
  year: 1989
  end-page: 3
  ident: CR21
  article-title: Low brain magnesium in migraine
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1989.hed2909590.x
– volume: 22
  start-page: 523
  year: 2002
  end-page: 5322
  ident: CR18
  article-title: The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis— a double-blind, multicentre, randomized placebo-controlled dose–response study
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2002.00396.x
– volume: 78
  start-page: 1346
  issue: 17
  year: 2012
  end-page: 53
  ident: CR27
  article-title: Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3182535d0c
– volume: 50
  start-page: S41
  issue: Suppl 1
  year: 2013
  end-page: 6
  ident: CR5
  article-title: The use of complementary and alternative medicine in patients with migraine
  publication-title: Arch Neuropsychiatr
  doi: 10.4274/npa.y6809
– volume: 21
  start-page: 1018
  issue: 4, Headache
  year: 2015
  end-page: 31
  ident: CR6
  article-title: Nutraceutical and other modalities for the treatment of headache
  publication-title: CONTINUUM: Lifelong Learn Neurol
– volume: 39
  start-page: S1
  issue: 2 Suppl 2
  year: 2012
  end-page: 59
  ident: CR32
  article-title: Canadian Headache Society guideline for migraine prophylaxis
  publication-title: Can J Neurol Sci
– volume: 14
  start-page: 283
  issue: 4
  year: 2001
  ident: 398_CR20
  publication-title: Magnes Res: Off Organ Int Soc Dev Res Magnes
– volume: 38
  start-page: 430
  issue: 9
  year: 2000
  ident: 398_CR15
  publication-title: Int J Clin Pharmacol Ther
  doi: 10.5414/CPP38430
– volume: 29
  start-page: 590
  year: 1989
  ident: 398_CR21
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1989.hed2909590.x
– volume: 22
  start-page: 345
  issue: 5
  year: 2002
  ident: 398_CR11
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2002.00364.x
– volume: 16
  start-page: 1
  issue: 1
  year: 2015
  ident: 398_CR2
  publication-title: J Headache Pain
  doi: 10.1186/s10194-015-0544-2
– volume: 89
  start-page: 633
  year: 1995
  ident: 398_CR22
  publication-title: Clin Sci
  doi: 10.1042/cs0890633
– volume: 20
  start-page: 1201
  issue: 9
  year: 2011
  ident: 398_CR47
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543784.2011.601741
– volume: 25
  start-page: 1031
  issue: 11
  year: 2005
  ident: 398_CR17
  publication-title: Cephalalgia
  doi: 10.1111/j.1468-2982.2005.00950.x
– volume: 19
  start-page: 422
  issue: 6
  year: 2009
  ident: 398_CR19
  publication-title: Pharmacogenet Genomics
  doi: 10.1097/FPC.0b013e32832af5a3
– volume: 39
  start-page: S1
  issue: 2 Suppl 2
  year: 2012
  ident: 398_CR32
  publication-title: Can J Neurol Sci
– volume: 63
  start-page: 2240
  year: 2004
  ident: 398_CR16
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000147290.68260.11
– volume: 18
  start-page: 704
  year: 1998
  ident: 398_CR42
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1998.1810704.x
– ident: 398_CR46
– volume: 42
  start-page: 114
  year: 2002
  ident: 398_CR25
  publication-title: Headache
  doi: 10.1046/j.1526-4610.2002.02026.x
– volume: 44
  start-page: 293
  issue: Suppl 2
  year: 1994
  ident: 398_CR39
  publication-title: Neurology
– volume: 8
  start-page: 653
  year: 1982
  ident: 398_CR36
  publication-title: Prostaglandins Leukot Med
– volume: 71
  start-page: 559
  issue: 8
  year: 2008
  ident: 398_CR4
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000323925.29520.e7
– volume: 11
  start-page: 508
  year: 1997
  ident: 398_CR41
  publication-title: Phytother Res
  doi: 10.1002/(SICI)1099-1573(199711)11:7<508::AID-PTR153>3.0.CO;2-H
– volume: 64
  start-page: 713
  issue: 4
  year: 2005
  ident: 398_CR30
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000151975.03598.ED
– volume: 40
  start-page: 743
  year: 1988
  ident: 398_CR35
  publication-title: J Pharm Pharmacol
  doi: 10.1111/j.2042-7158.1988.tb07010.x
– volume: 22
  start-page: 523
  year: 2002
  ident: 398_CR18
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2002.00396.x
– volume: 32
  start-page: 719
  issue: 9
  year: 2012
  ident: 398_CR45
  publication-title: Cephalalgia
  doi: 10.1177/0333102412451357
– volume: 22
  start-page: 137
  year: 2002
  ident: 398_CR29
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2002.00335.x
– volume: 50
  start-page: S41
  issue: Suppl 1
  year: 2013
  ident: 398_CR5
  publication-title: Arch Neuropsychiatr
  doi: 10.4274/npa.y6809
– volume: 45
  start-page: 196
  year: 2005
  ident: 398_CR14
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2005.05044.x
– volume: 291
  start-page: 569
  year: 1985
  ident: 398_CR37
  publication-title: Br Med J
  doi: 10.1136/bmj.291.6495.569
– volume: 29
  start-page: 135
  year: 2009
  ident: 398_CR26
  publication-title: Cephalalgia
  doi: 10.1111/j.1468-2982.2009.01849.x
– volume: 21
  start-page: 2
  issue: 1
  year: 2014
  ident: 398_CR28
  publication-title: Eur J Emerg Med
– volume: 39
  start-page: 459
  year: 1987
  ident: 398_CR34
  publication-title: J Pharm Pharmacol
  doi: 10.1111/j.2042-7158.1987.tb03420.x
– volume: 16
  start-page: 257
  issue: 4
  year: 1996
  ident: 398_CR10
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1996.1604257.x
– volume: 325
  start-page: 1071
  issue: 8437
  year: 1985
  ident: 398_CR33
  publication-title: Lancet
  doi: 10.1016/S0140-6736(85)92371-2
– volume: 80
  start-page: S40
  issue: Meeting Abstrac
  year: 2013
  ident: 398_CR48
  publication-title: Neurology
– volume: 47
  start-page: 73
  year: 2007
  ident: 398_CR12
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2007.00652.x
– volume: 50
  start-page: 466
  year: 1998
  ident: 398_CR13
  publication-title: Neurology
  doi: 10.1212/WNL.50.2.466
– volume: 72
  start-page: 1588
  issue: 18
  year: 2009
  ident: 398_CR31
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181a41269
– volume: 34
  start-page: 160
  issue: 3
  year: 1994
  ident: 398_CR24
  publication-title: Headache: J Head Face Pain
  doi: 10.1111/j.1526-4610.1994.hed3403160.x
– volume: 2
  start-page: 189
  year: 1988
  ident: 398_CR38
  publication-title: Lancet
  doi: 10.1016/S0140-6736(88)92289-1
– volume: 51
  start-page: 469
  issue: 3
  year: 2011
  ident: 398_CR7
  publication-title: Headache: J Head Face Pain
  doi: 10.1111/j.1526-4610.2011.01846.x
– volume: 30
  start-page: 065
  year: 2010
  ident: 398_CR1
  publication-title: Cephalalgia
  doi: 10.1177/0333102409355601
– volume: 3
  start-page: 225
  issue: 3
  year: 1996
  ident: 398_CR40
  publication-title: Phytomedicine
  doi: 10.1016/S0944-7113(96)80057-2
– volume: 18
  start-page: 796
  issue: 4, Headache
  year: 2012
  ident: 398_CR8
  publication-title: CONTINUUM: Lifelong Learn Neurol
– volume: 16
  start-page: 436
  issue: 6
  year: 1996
  ident: 398_CR9
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1996.1606436.x
– volume: 136
  start-page: 23
  issue: 10
  year: 2003
  ident: 398_CR43
  publication-title: CPJ, Can Pharm J
– volume: 50
  start-page: 349
  issue: 6
  year: 2011
  ident: 398_CR44
  publication-title: Clin Pharmacokinet
  doi: 10.2165/11586800-000000000-00000
– volume: 15
  start-page: 344
  issue: 4
  year: 2015
  ident: 398_CR3
  publication-title: Clin Med
  doi: 10.7861/clinmedicine.15-4-344
– volume: 13
  start-page: 94
  issue: 2
  year: 1993
  ident: 398_CR23
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1993.1302094.x
– volume: 21
  start-page: 1018
  issue: 4, Headache
  year: 2015
  ident: 398_CR6
  publication-title: CONTINUUM: Lifelong Learn Neurol
– volume: 78
  start-page: 1346
  issue: 17
  year: 2012
  ident: 398_CR27
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3182535d0c
– reference: 28360583 - Noro Psikiyatr Ars. 2013 Aug;50(Suppl 1):S41-S46
– reference: 21819271 - Expert Opin Investig Drugs. 2011 Sep;20(9):1201-10
– reference: 11972582 - Cephalalgia. 2002 Mar;22(2):137-41
– reference: 17355497 - Headache. 2007 Jan;47(1):73-80
– reference: 8200791 - Headache. 1994 Mar;34(3):160-5
– reference: 9950629 - Cephalalgia. 1998 Dec;18(10):704-8
– reference: 11794636 - Magnes Res. 2001 Dec;14(4):283-90
– reference: 15728298 - Neurology. 2005 Feb 22;64(4):713-5
– reference: 16232154 - Cephalalgia. 2005 Nov;25(11):1031-41
– reference: 26407383 - Clin Med (Lond). 2015 Aug;15(4):344-50
– reference: 9484373 - Neurology. 1998 Feb;50(2):466-70
– reference: 15836592 - Headache. 2005 Mar;45(3):196-203
– reference: 8549082 - Clin Sci (Lond). 1995 Dec;89(6):633-6
– reference: 22868542 - Continuum (Minneap Minn). 2012 Aug;18(4):796-806
– reference: 8495462 - Cephalalgia. 1993 Apr;13(2):94-81; discussion 73
– reference: 19384265 - Pharmacogenet Genomics. 2009 Jun;19(6):422-8
– reference: 2886604 - J Pharm Pharmacol. 1987 Jun;39(6):459-65
– reference: 20713557 - Cephalalgia. 2010 Sep;30(9):1065-72
– reference: 2860288 - Lancet. 1985 May 11;1(8437):1071-4
– reference: 23195074 - Phytomedicine. 1996 Nov;3(3):225-30
– reference: 22683887 - Can J Neurol Sci. 2012 Mar;39(2 Suppl 2):S1-59
– reference: 22767962 - Cephalalgia. 2012 Jul;32(9):719-22
– reference: 12005285 - Headache. 2002 Feb;42(2):114-9
– reference: 21352222 - Headache. 2011 Mar;51(3):469-483
– reference: 8902254 - Cephalalgia. 1996 Oct;16(6):436-40
– reference: 8792038 - Cephalalgia. 1996 Jun;16(4):257-63
– reference: 15623680 - Neurology. 2004 Dec 28;63(12):2240-4
– reference: 21553931 - Clin Pharmacokinet. 2011 Jun;50(6):349-69
– reference: 2899663 - Lancet. 1988 Jul 23;2(8604):189-92
– reference: 2584000 - Headache. 1989 Oct;29(9):590-3
– reference: 12110110 - Cephalalgia. 2002 Jun;22(5):345-53
– reference: 23921817 - Eur J Emerg Med. 2014 Feb;21(1):2-9
– reference: 18711108 - Neurology. 2008 Aug 19;71(8):559-66
– reference: 2907548 - J Pharm Pharmacol. 1988 Oct;40(10 ):743-5
– reference: 19414726 - Neurology. 2009 May 5;72(18):1588-94
– reference: 3929876 - Br Med J (Clin Res Ed). 1985 Aug 31;291(6495):569-73
– reference: 26109437 - J Headache Pain. 2015;16:58
– reference: 11020030 - Int J Clin Pharmacol Ther. 2000 Sep;38(9):430-5
– reference: 6810384 - Prostaglandins Leukot Med. 1982 Jun;8(6):653-60
– reference: 12230594 - Cephalalgia. 2002 Sep;22(7):523-32
– reference: 26252588 - Continuum (Minneap Minn). 2015 Aug;21(4 Headache):1018-31
– reference: 22529203 - Neurology. 2012 Apr 24;78(17):1346-53
SSID ssj0025411
Score 2.227407
SecondaryResourceType review_article
Snippet Opinion statement People who suffer from headaches often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible...
People who suffer from headaches often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible side effects, drug...
OPINION STATEMENTPeople who suffer from headaches often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 14
SubjectTerms Critical Care Medicine
Diabetes
Family Medicine
General Practice
Headache (JR Couch
Intensive
Internal Medicine
Medicine
Medicine & Public Health
Neurology
Ophthalmology
Section Editor
Topical Collection on Headache
Title Nutraceuticals in Acute and Prophylactic Treatment of Migraine
URI https://link.springer.com/article/10.1007/s11940-016-0398-1
https://www.ncbi.nlm.nih.gov/pubmed/26923604
https://www.proquest.com/docview/1769619463
Volume 18
WOSCitedRecordID wos000372252900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1534-3138
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0025411
  issn: 1092-8480
  databaseCode: RSV
  dateStart: 19990201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB60injx_aiPsoInJZDHZrN7EYpYvLQUrdJb2OxDCiWRJvX3u5smKVIV9L7ZhJmdzMx-M_MBXOMwUERi7PiSEQdjzh2mGXUCnYSe1NK4GF2STUSDAR2P2bDq487ravcakiz_1MtmN5Nv2yIqkwEHZjeT8mwYb0ctX8PT82uTZYW4JN31XGZMHdMGyvxui6_OaCXCXEFHS6fT2_3X5-7BThVjou7iUOzDmkoPYKtfoeiHcDeYF7PmHjtHkxR1xbxQiKcSDWeZkfy07J1Co7oMHWUa9Sdvlk9CHcFL72F0_-hUPAqOCDAuHKyF9hJJFA2l8JQKtK8FJ1LxKGRCh1opJhKfShIKzsMkwizytaSupkzbFPYYWmmWqlNALk-4KKEaV5hASiVSe5FIsM9xQKNEtsGtBRqLasi45bqYxsvxyFYusS0ss3KJvTbcNI-8LyZs_Lb4qtZSbOzAghs8Vdk8j72IMHsjQ4I2nCzU12znExPGEhe34bbWVVyZav7zu87-tPoctv1S2bao5wJaxWyuLmFTfBSTfNaB9WhMO-VB_QRoiOCF
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8NAEB5ERX3xPuq5gk9KIMdmk30RilgqtqVolb6FzR5SKIk0qb_f3TRJkaqg77uTZWYnM7PfHABX2PckERhbrqDEwpgxiyoaWp6KfUcooU2MKoZNBL1eOBzSflnHnVXZ7hUkWfyp58VuOt42SVQ6AvY0NR3yrGBtsEzD_Kfn1zrK8nExdNexqVZ1HNZQ5nckvhqjBQ9zAR0tjE5r61_H3YbN0sdEzdml2IElmezCWrdE0ffgtjfNJ_U7doZGCWryaS4RSwTqT1LN-XFRO4UGVRo6ShXqjt7MPAm5Dy-t-8Fd2yrnKFjcwzi3sOLKiQWRoS-4I6WnXMUZEZIFPuXKV1JSHruhID5nzI8DTANXidBWIVUmhD2A5SRN5BEgm8WMF1CNzbUjJWOhnIDH2GXYC4NYNMCuGBrxssm4mXUxjubtkQ1fIpNYZvgSOQ24rre8zzps_Lb4spJSpPXAgBsskek0i5yAUPMiQ7wGHM7EV5NziXZjiY0bcFPJKipVNfv5W8d_Wn0B6-1BtxN1HnqPJ7DhFoI3CT6nsJxPpvIMVvlHPsom58V1_QStZ-KB
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8NAEB6kSvHF-6jnCj4poTk2m-yLUNSiaEvBKn0Lmz2kUNLSpP5-d9MkRaqC-L7ZDTM7zMx-38wAXGLfk0RgbLmCEgtjxiyqaGh5KvYdoYR2MSofNhF0u-FgQHvFnNO0ZLuXkOS8psF0aUqy5kSo5qLwTefehlCls2FP76zTn1VsePQmXX95qzIuH-cDeB2barPHYQVrfrfFV8e0FG0uIaW5A2pv_vvXt2CjiD1Ra35ZtmFFJjtQ7xTo-i7cdGfZtHrfTtEwQS0-yyRiiUC96VhrZJTXVKF-SU9HY4U6w3czZ0LuwWv7vn_7YBXzFSzuYZxZWHHlxILI0BfckdJTruKMCMkCn3LlKykpj91QEJ8z5scBpoGrRGirkCqT2u5DLRkn8hCQzWLGcwjH5jrAkrFQTsBj7DLshUEsGmCXwo140XzczMAYRYu2yUYukSGcGblETgOuqk8m884bvy2-KDUWafswoAdL5HiWRk5AqHmpIV4DDuaqrLZziQ5viY0bcF3qLSpMOP35rKM_rT6Heu-uHT0_dp-OYd3N9W54PydQy6YzeQpr_CMbptOz_OZ-AlDT62U
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nutraceuticals+in+Acute+and+Prophylactic+Treatment+of+Migraine&rft.jtitle=Current+treatment+options+in+neurology&rft.au=Daniel%2C+Oved&rft.au=Mauskop%2C+Alexander&rft.date=2016-04-01&rft.issn=1092-8480&rft.eissn=1534-3138&rft.volume=18&rft.issue=4&rft_id=info:doi/10.1007%2Fs11940-016-0398-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11940_016_0398_1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1092-8480&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1092-8480&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1092-8480&client=summon